- Home
- CTSO vs SWIN Comparison
CTSO vs SWIN Comparison
Compare CTSO & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- SWIN
- Stock Information
- Founded
- CTSO 1997
- SWIN 2017
- Country
- CTSO United States
- SWIN Hong Kong
- Employees
- CTSO N/A
- SWIN 33
- Industry
- CTSO Medical/Dental Instruments
- SWIN
- Sector
- CTSO Health Care
- SWIN
- Exchange
- CTSO Nasdaq
- SWIN Nasdaq
- Market Cap
- CTSO 61.7M
- SWIN 541.0M
- IPO Year
- CTSO N/A
- SWIN 2023
- Fundamental
- Price
- CTSO $0.92
- SWIN $2.67
- Analyst Decision
- CTSO Buy
- SWIN
- Analyst Count
- CTSO 2
- SWIN 0
- Target Price
- CTSO $5.50
- SWIN N/A
- AVG Volume (30 Days)
- CTSO 130.7K
- SWIN 1.6M
- Earning Date
- CTSO 11-06-2025
- SWIN 06-30-2025
- Dividend Yield
- CTSO N/A
- SWIN N/A
- EPS Growth
- CTSO N/A
- SWIN N/A
- EPS
- CTSO N/A
- SWIN N/A
- Revenue
- CTSO $36,107,520.00
- SWIN $3,316,000.00
- Revenue This Year
- CTSO $11.93
- SWIN $29.79
- Revenue Next Year
- CTSO $21.22
- SWIN $54.60
- P/E Ratio
- CTSO N/A
- SWIN N/A
- Revenue Growth
- CTSO 20.18
- SWIN N/A
- 52 Week Low
- CTSO $0.71
- SWIN $1.16
- 52 Week High
- CTSO $1.61
- SWIN $5.09
- Technical
- Relative Strength Index (RSI)
- CTSO 45.27
- SWIN 39.01
- Support Level
- CTSO $0.87
- SWIN $2.45
- Resistance Level
- CTSO $0.95
- SWIN $2.90
- Average True Range (ATR)
- CTSO 0.05
- SWIN 0.45
- MACD
- CTSO -0.00
- SWIN -0.04
- Stochastic Oscillator
- CTSO 33.85
- SWIN 12.90
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.